Insider · CIK 0001814673

Heyman Tomas J.

Reports to the SEC for 6 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001814673

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	LEGNLegend Biotech CorpA Award	Director	AAward	+21K sh	—	—	53,720
2026-05-27	EXELEXELIXIS, INC.A Award	Director	AAward	+8,367 sh	—	—	50,649
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,398 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2025-06-03	Akero Therapeutics, Inc.A Award	Director	AAward	+9,398 sh	—	—	9,398
2025-05-29	EXELEXELIXIS, INC.A Award	Director	AAward	+9,812 sh	—	—	42,282
2025-05-21	OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-05-21	OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,566 sh	—	—	0
2025-05-21	OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,133 sh	—	—	0
2025-05-21	OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−962 sh	—	—	0
2025-05-21	OptiNose, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,925 sh	—	—	0
2025-05-21	EXELEXELIXIS, INC.S Sale	Director	SSale	−4,544 sh	$44.29	−$201K	32,470
2024-06-08	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2024-06-06	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2024-05-31	EXELEXELIXIS, INC.A Award	Director	AAward	+18.8K sh	—	—	37,014
2023-06-23	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-16	Akero Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26K sh	$25.04	+$651K	26,000
2023-06-16	Akero Therapeutics, Inc.S Sale	Director	SSale	−26K sh	$54.67	−$1.42M	0
2023-06-16	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−26K sh	—	—	0
2023-06-12	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,200
2023-06-08	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+53.5K sh	—	—	53,500
2023-05-31	EXELEXELIXIS, INC.A Award	Director	AAward	+18.2K sh	—	—	18,176
2023-05-31	EXELEXELIXIS, INC. · Option (right to buy)A Award	Director	AAward	+36.4K sh	—	—	36,353
2023-05-23	IVVDInvivyd, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-09-15	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26.4K sh	—	—	26,400
2022-06-22	IVVDInvivyd, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2022-06-08	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2022-06-02	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-09	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,439
2021-06-01	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2020-12-01	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28.9K sh	—	—	28,879
2020-06-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	−26K sh	—	—	26,000

Recent filings

Accepted (ET)
Sep 284
Heyman Tomas J.0001814673-26-000005
SEC(opens sec.gov)
May 294
Heyman Tomas J.0000939767-26-000082
SEC(opens sec.gov)
Dec 94
Heyman Tomas J.0001193125-25-312134
SEC(opens sec.gov)
Jun 54
Heyman Tomas J.0000950170-25-082307
SEC(opens sec.gov)
May 304
Heyman Tomas J.0000939767-25-000092
SEC(opens sec.gov)
May 224
Heyman Tomas J.0000939767-25-000084
SEC(opens sec.gov)
May 214
Heyman Tomas J.0001104659-25-051341
SEC(opens sec.gov)
Jun 114
Heyman Tomas J.0000950170-24-072069
SEC(opens sec.gov)
Jun 74
Heyman Tomas J.0001494650-24-000083
SEC(opens sec.gov)
Jun 44
Heyman Tomas J.0000939767-24-000099
SEC(opens sec.gov)
Jun 274
Heyman Tomas J.0000950170-23-030218
SEC(opens sec.gov)
Jun 214
Heyman Tomas J.0000950170-23-029231
SEC(opens sec.gov)

Companies

Address

C/O LEGEND BIOTECH CORP 77 CORPORATE DRIVE, 4TH FLOOR

BRIDGEWATER, NJ, 08807